In continuation of its letter dated January 28, 2023 and pursuant to Regulation 30(6) read with Part A of Schedule III of the Listing Regulations, Thyrocare Technologies has informed that the audio recording of earning conference calls for Analysts and Investors held on February 03, 2023, with respect to Company’s financial results for quarter and nine months ended December 31, 2022 is available on the Company’s website https://investor.thyrocare.com/financials/quarterly-financial-results/ .The transcript of earning calls will be shared shortly.
The above information is a part of company’s filings submitted to BSE.
